Literature DB >> 19461673

Regulation of innate immune responses in the brain.

Serge Rivest1.   

Abstract

Microglial cells are the main innate immune cells of the complex cellular structure of the brain. These cells respond quickly to pathogens and injury, accumulate in regions of degeneration and produce a wide variety of pro-inflammatory molecules. These observations have resulted in active debate regarding the exact role of microglial cells in the brain and whether they have beneficial or detrimental functions. Careful targeting of these cells could have therapeutic benefits for several types of trauma and disease specific to the central nervous system. This Review discusses the molecular details underlying the innate immune response in the brain during infection, injury and disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19461673     DOI: 10.1038/nri2565

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   53.106


  108 in total

1.  Targeting gene-modified hematopoietic cells to the central nervous system: use of green fluorescent protein uncovers microglial engraftment.

Authors:  J Priller; A Flügel; T Wehner; M Boentert; C A Haas; M Prinz; F Fernández-Klett; K Prass; I Bechmann; B A de Boer; M Frotscher; G W Kreutzberg; D A Persons; U Dirnagl
Journal:  Nat Med       Date:  2001-12       Impact factor: 53.440

2.  Cultured astrocytes express toll-like receptors for bacterial products.

Authors:  Christal C Bowman; Amy Rasley; Susanne L Tranguch; Ian Marriott
Journal:  Glia       Date:  2003-09       Impact factor: 7.452

Review 3.  Drug insight: selective agonists and antagonists of the glucocorticoid receptor.

Authors:  Andrew McMaster; David W Ray
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2008-02

4.  Acute bacterial meningitis in adults. A 20-year overview.

Authors:  B Sigurdardóttir; O M Björnsson; K E Jónsdóttir; H Erlendsdóttir; S Gudmundsson
Journal:  Arch Intern Med       Date:  1997-02-24

5.  Cognitive function over time in the Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT): results of a randomized, controlled trial of naproxen and celecoxib.

Authors:  Barbara K Martin; Christine Szekely; Jason Brandt; Steven Piantadosi; John C S Breitner; Suzanne Craft; Denis Evans; Robert Green; Michael Mullan
Journal:  Arch Neurol       Date:  2008-05-12

6.  Circulating cell wall components derived from gram-negative, not gram-positive, bacteria cause a profound induction of the gene-encoding Toll-like receptor 2 in the CNS.

Authors:  N Laflamme; G Soucy; S Rivest
Journal:  J Neurochem       Date:  2001-11       Impact factor: 5.372

7.  The basic helix-loop-helix factor olig2 is essential for the development of motoneuron and oligodendrocyte lineages.

Authors:  Hirohide Takebayashi; Yoko Nabeshima; Shosei Yoshida; Osamu Chisaka; Kazuhiro Ikenaka; Yo-ichi Nabeshima
Journal:  Curr Biol       Date:  2002-07-09       Impact factor: 10.834

8.  Toll-like receptor 9: a new target of ischemic preconditioning in the brain.

Authors:  Susan L Stevens; Thomas M P Ciesielski; Brenda J Marsh; Tao Yang; Delfina S Homen; Jo-Lynn Boule; Nikola S Lessov; Roger P Simon; Mary P Stenzel-Poore
Journal:  J Cereb Blood Flow Metab       Date:  2008-01-09       Impact factor: 6.200

9.  PDGF receptors in the rat CNS: during late neurogenesis, PDGF alpha-receptor expression appears to be restricted to glial cells of the oligodendrocyte lineage.

Authors:  N P Pringle; H S Mudhar; E J Collarini; W D Richardson
Journal:  Development       Date:  1992-06       Impact factor: 6.868

10.  Innate immunity and transcription of MGAT-III and Toll-like receptors in Alzheimer's disease patients are improved by bisdemethoxycurcumin.

Authors:  Milan Fiala; Philip T Liu; Araceli Espinosa-Jeffrey; Mark J Rosenthal; George Bernard; John M Ringman; James Sayre; Laura Zhang; Justin Zaghi; Sheila Dejbakhsh; Ben Chiang; James Hui; Michelle Mahanian; Anita Baghaee; Pamela Hong; John Cashman
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-24       Impact factor: 11.205

View more
  338 in total

1.  Primary murine microglia are resistant to nitric oxide inhibition of indoleamine 2,3-dioxygenase.

Authors:  Yunxia Wang; Marcus A Lawson; Keith W Kelley; Robert Dantzer
Journal:  Brain Behav Immun       Date:  2010-05-06       Impact factor: 7.217

2.  The fractalkine receptor but not CCR2 is present on microglia from embryonic development throughout adulthood.

Authors:  Makiko Mizutani; Paula A Pino; Noah Saederup; Israel F Charo; Richard M Ransohoff; Astrid E Cardona
Journal:  J Immunol       Date:  2011-11-11       Impact factor: 5.422

Review 3.  MicroRNAs: novel regulators of oligodendrocyte differentiation and potential therapeutic targets in demyelination-related diseases.

Authors:  Jia-Su Li; Zhong-Xiang Yao
Journal:  Mol Neurobiol       Date:  2012-01-05       Impact factor: 5.590

Review 4.  Immunology as it pertains to drugs of abuse, AIDS and the neuroimmune axis: mediators and traffic.

Authors:  Thomas J Rogers
Journal:  J Neuroimmune Pharmacol       Date:  2010-10-19       Impact factor: 4.147

5.  Responses of glial cells to stress and glucocorticoids.

Authors:  F Jauregui-Huerta; Y Ruvalcaba-Delgadillo; R Gonzalez-Castañeda; J Garcia-Estrada; O Gonzalez-Perez; S Luquin
Journal:  Curr Immunol Rev       Date:  2010-08-01

Review 6.  MicroRNAs regulate the chaperone network in cerebral ischemia.

Authors:  Yi-Bing Ouyang; Rona G Giffard
Journal:  Transl Stroke Res       Date:  2013-08-17       Impact factor: 6.829

Review 7.  Therapeutic Hypothermia and Neuroprotection in Acute Neurological Disease.

Authors:  Kota Kurisu; Jong Youl Kim; Jesung You; Midori A Yenari
Journal:  Curr Med Chem       Date:  2019       Impact factor: 4.530

8.  Toll-like receptor 4 stimulation with the detoxified ligand monophosphoryl lipid A improves Alzheimer's disease-related pathology.

Authors:  Jean-Philippe Michaud; Maxime Hallé; Antoine Lampron; Peter Thériault; Paul Préfontaine; Mohammed Filali; Pascale Tribout-Jover; Anne-Marie Lanteigne; Rachel Jodoin; Christopher Cluff; Vincent Brichard; Rémi Palmantier; Anthony Pilorget; Daniel Larocque; Serge Rivest
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-15       Impact factor: 11.205

9.  Systemic LPS induces spinal inflammatory gene expression and impairs phrenic long-term facilitation following acute intermittent hypoxia.

Authors:  A G Huxtable; S M C Smith; S Vinit; J J Watters; G S Mitchell
Journal:  J Appl Physiol (1985)       Date:  2013-01-17

10.  miR-140-5p Attenuates Neuroinflammation and Brain Injury in Rats Following Intracerebral Hemorrhage by Targeting TLR4.

Authors:  Shunda Wang; Yujie Cui; Jiaqi Xu; Heng Gao
Journal:  Inflammation       Date:  2019-10       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.